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INTRODUCTION
1INTRODUCTION
Bronchiolitis remains one of the greatest clinical challenges
in pediatric care. Bronchiolitis is a disease of lower respiratory tract that
occurs in young children (below 2yrs) and caused by infection with
seasonal virus such as RSV, influenza, Adenovirus, influenza and etc.
It is a leading cause for the hospitalization of young children,
associated with high degree of morbidity but low mortality (<1%). About
20% of infants in the United States get bronchiolitis each year and 2-3%
of them require hospitalization. Children younger than one year of age are
almost twice as likely to develop bronchiolitis. Currently there is no
enough data to determine bronchiolitis rate in the developing and
underdeveloped countries.
Definition of bronchiolitis varies between the published
studies. As per AAP guideline1 defined bronchiolitis as “a constellation
of clinical symptoms and signs including upper respiratory prodrome
followed by increased respiratory effort and wheezing in children less the
two years of age.”
There are many medical factors which increases the risk of severity
of the disease such as prematurity, low birth weight, chronic lung disease,
2congenital heart disease and immunodeficiency (congenital and
acquired).
In addition to this, there are many non medical factors which also
increase the severity of the disease, thereby leading to increased
hospitalization rates. The non medical risk factors are feeding practices
(breast feeding or bottle feeding), family history of asthma, passive
smoking, indoor allergens (wood burning stove and mosquito coils),
overcrowding, number of sibling in the family and lower socio-economic
status.
Many studies have documented the association of non medical
factors with severity of the disease, some of which are easily preventable.
Nowadays studies are more concentrating on the management of the
disease rather than prevention of these factors which are more effective
method to reduce the morbidity of the disease.
Hence it is time to emphasize the importance of the prevention of
non medical risk factors to reduce the hospitalization rate and duration of
the hospital stay.
Review Of
Literature
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History
Jeffrey et al2 he mentioned that bronchiolitis was first described as
a distinct clinical entity in 1941 after a small influenza epidemic affected
a large number of young children in the United Kingdom.
Hubble and Osborn3 wrote that “acute bronchiolitis is the essential
pulmonary lesion in epidemic influenza… This condition is particularly
common in young children, in whom it produces urgent dyspnoea and, if
not vigorously treated, death by asphyxia.”
Since that time, many more viruses have been implicated in
bronchiolitis, including respiratory syncytial virus (RSV) and human
Metapneumovirus. It has become one of the most common diagnoses
made by pediatric emergency physicians.
Definition
Definitions of bronchiolitis vary and may account for some of the
variability in the clinical evidence derived from published studies.
In the United Kingdom, the authors of University of Nottingham
study derived a consensus definition of “a seasonal viral illness
4characterized by fever, nasal discharge, and dry, wheezy cough. On
examination there are fine inspiratory crackles and/or high-pitched
expiratory wheeze.”4
As per AAP guideline1, bronchiolitis is a “constellation of clinical
symptoms and signs of a viral upper respiratory prodrome followed by
increased respiratory effort and wheezing in children less than 2 years of
age.”
Burden of bronchiolitis
RSV bronchiolitis is recognized as the most important cause of
serious lower respiratory tract illness in infants and young children
worldwide leading to hospitalization in a great number of cases.
According to AAP1, the epidemiologic study results of
bronchiolitis have suggested a high degree of morbidity but low
mortality. More than one third of children develop bronchiolitis during
the first 2 years of life. Of these, 3% of all infants in the United States
will be hospitalized, up from approximately 1% in the 1970s.
 SIGN5 (Scottish Intercollegiate Guideline Network) 2006, nation
clinical guidelines stated that the burden of the disease is significant. 3%
of all infants younger than one year of age are admitted to hospital with
5bronchiolitis. In Hong Kong study by R.Y.T.Sungi et al6, they accounted
for 6.6% of total pediatrics admissions.
Incidence of hospitalization
Hans-Olav Fjaerli et al7 in his population based retrospective study,
he found that mean annual hospitalization incidence were 21.7 per 1000
children under one year of age, 6.8 per 1000 children at 1 – 2 years of age
and 14.1per 1000 under 2 years of age.
R.Y.T.Sungi et al6 in his study, found that a case incidence of
bronchiolitis requiring admission to hospital was about 21 per 1000
children under 2 years of age.  John et al9 wrote that acute bronchiolitis
also occurs in developing countries in the tropics; there is limited
knowledge about its cause and epidemiology in tropical regions of the
world.
Few studies attempted to quantify the incidence rates of RSV
infection in developing countries. (Borrero et al10. 1990; Dagan et al11.
1993). The reported incidence rates vary between 10/1000 children under
one year of life for hospitalization with RSV-ALRI in southern Israel11, to
198/1000 child years for the age group between birth and 18 months in a
community-based study from Colombia10.
6Etiology
Wright  AL  et  al12 mentioned that RSV continues to account for
50% to 80% of bronchiolitis cases. Other causes include the
parainfluenza viruses type 3, influenza, Human Metapneumovirus
(HMPV), rhinovirus, adenovirus and etc.,
Boivin et al13 in his extensive study on human Metapneumovirus,
they found that HMPV has been estimated to account for 3% to 19% of
bronchiolitis cases.
John et al9 was done a study in South India, he found that in South
India, acute bronchiolitis tended to occur in outbreaks between August
and November, coincided with RSV outbreaks. These findings suggest
that bronchiolitis is a viral rather than bacterial disease.
Semple MG et al18 was found that the rate of co- infection have
ranged from 10% to 30% of hospitalized children, most commonly with
RSV and either HMPV or rhinovirus.
One study from Delhi15, Viral identification rate was 46.12%. RSV
was isolated in 29.38%, adenovirus in 7.75%, influenza virus (type A
&B) in 1.22%, parainfluenza virus in 3.67 %, rhinovirus in 5.31% and
7Metapneumovirus in 10.88%. Mixed infections were documented in 6.6%
of cases.
Rakes GP et al16 found that the role of rhino virus is unclear
because of their well documented role in triggering exacerbations of
wheezing among older children with reactive airway disease or asthma.
Respiratory Syncytial Virus
RSV causes 85% of all bronchiolitis. It is highly contagious and
can be spread through physical contact (kissing, shaking hands) or
through with inanimate objects (toys, towels) that an infected person has
touched.
RSV can survive for 30mins on a person’s hands and for as many
as 5 hours on objects. It can become airborne when infected persons
sneeze and cough or laugh, and enter the body through eyes and nose. In
most cases infected by family members, friends or children who attend
the same daycare.
Pathogenesis
The pathological picture of bronchiolitis is important in
understanding the clinical manifestations and developing rational
management.
8The type of injury and clinical manifestations of the respiratory
tract induced by viral diseases are probably consequences of the
combination of the viral affinity for specific cells in segments of the
airways (tropism), the destructive effect at the cellular level (virulence),
the size of the respiratory passage in the host, and the immunologic
response elicited.
Although RSV is one of the least destructive of the respiratory
viruses in vitro, its high affinity for the bronchial epithelium explains the
tendency to produce major respiratory disease. Inoculation of RSV
presumably occurs through the nasal mucosa surface then spreading to
the lower respiratory tract mechanism which is poorly understood,
presumably through aspiration of infected secretions which produce
bronchiolitis17.
The primary immune response consists of tissue infiltration by
recruited polymorphonuclear leukocytes and macrophages after the
release of chemical messengers from damaged epithelial cells. These cells
release more mediators, which alter endothelial permeability, epithelial
junctions, and ion transport, thereby exacerbating inflammation with
additional cell recruitment and promoting edema18. The increased luminal
contents with secretions and cellular debris account in part for airway
9obstruction, limiting air flow, and producing atelectasis and a consequent
ventilation-perfusion mismatch.
Gardner PS et al19 in his study on pathogenesis of RSV he
mentioned that smooth muscle contraction is another mechanism of
airway obstruction. Besides abnormalities of the adrenergic and
cholinergic systems during respiratory viruses, the non-adrenergic non-
cholinergic system (NANC) can also induce bronchoconstriction
following epithelial damage. Neuropeptides are the chemical mediators of
this system. Some of them (e.g., substance P, tachykinins, and calcitonin
gene-related peptide [CGRP]) have the potential of inducing obstruction,
but their role in bronchiolitis requires further elucidation20 which may
explain the limited benefit of bronchodilators observed in clinical studies.
The decrease of T-suppressor lymphocytes with increased T-
helper/T-suppressor ratios could play a role in the pathogenesis of acute
bronchiolitis, allowing IgE hyper production and alveolar mast cell
activation21. The specific cell response to RSV seems to be more intense
in children under six months and in more severe cases22.
Some authors state that antigen-antibody complexes could
participate in the pathogenesis of bronchiolitis. The maternal neutralizing
antibodies against RSV, passively acquired by the fetus, might be
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responsible for the high incidence of the disease in the first months of
life. Other findings contradict this hypothesis in reporting no correlation
between passive and active antibodies and severity of the disease23.
Glezen et al24 in a prospective, randomized study of risk factors in
bronchiolitis admitted that passive antibodies might be protective.
 The pathogenic mechanisms in bronchiolitis are still obscure. The
ability to recover after RSV infection is related to IgA, IgG, and IgM
secretory immunoglobulin levels and antibody-dependent, cell-mediated
cytotoxicity (ADCC). These mechanisms could account for the mild
symptoms seen in re-infections. The variation in clinical findings in small
children might result from underdeveloped individual host defenses17.
Clinical Features
Iqbal et al25 found that mean age of children was 11.3 ± 5.6
months. Other studies by Uyan26 and Arif A27 reported relatively younger
age groups (6.9 ± 3.4 months, 5.4 ± 9.4 months, respectively). This
difference may be due to small sample size in their studies. He also
documented an overall male preponderance (57%), which was similar to
studies by Uyan26 (58%) and Arif A27(68%).
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AAP1 stated that in their guideline, the highest incidence of RSV
occurring between December and March. Hans-Olav Fjaerli et al7 done a
population based retrospective study in Northern Europe; he reported that
the high number of admission was recorded during winter months
December – April. John et al9 done a study in South India, he stated that
acute bronchiolitis tented to occur in outbreaks between August and
November.
In Hong Kong, R.Y.T.Sungi et al6 in his study, he surprised to find
that acute bronchiolitis was prevalent in the middle part of the year,
between April and October. In sharp contrast with that reports from
U.S29, from U.K19 and from Australia29, they found that epidemic of acute
bronchiolitis invariably occur in winter and early spring.
RSV infections occur most frequently in the cold season in areas
with temperate and Mediterranean climates and in the wet season in
tropical countries with seasonal rainfall. The age group mainly affected
by RSV in developing countries is children less than 6 months of age.
RSV-ALRI is slightly more common in boys than in girls30.
Pinnington LL et al31 clearly stated that most aspects of feeding are
less efficient during periods of respiratory illness and Coordination of
breathing during feeding is also significantly impaired.
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A  Maffey et al32 concluded that there was a no risk of aspiration
during acute RSV-bronchiolitis. Aspiration is likely to play a role when
rapid deterioration occurs in infants with RSV bronchiolitis33.
Oski’s pediatric textbook34 quote that infants with RSV
bronchiolitis may be high risk for aspiration which also may be manifest
as wheezing.
Early symptoms are those of viral upper respiratory tract infections
including mild rhinorrhea, cough and sometimes low-grade fever. Sixty
percent of primary RSV infections are confined to the upper airway.
During a period of 2-5 days this may progress to lower respiratory tract
involvement with the development of cough, dyspnea, wheezing and
feeding difficulties. Severe cases progress to respiratory distress with
tachypnea, nasal flaring, retractions, irritability and cyanosis26.
Iqbal et al25, he studied on total of 107 children among age group
between 2months to 2years, he found that 91% had respiratory distress at
the time of presentation, 76% had nasal flaring, 72% wheezing, 64% had
fever, 41% retractions and 32% had decreased feeding. A previous
study27 concluded that respiratory distress (97.5%) was consistent clinical
feature.
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Clinical Course
Most patients have mild clinical illness and recover uneventfully in
5-7 days but coughing may persist for up to 2 weeks35. Median hospital
stay for normal children is 3-5 days and less than 10% require
ventilation36. Most will have normal respiratory parameters 2 weeks after
the height of the illness and radiologic abnormalities will clear within 9
days of admission. However, 20% of normal children will have a
protracted course with wheezing and abnormal pulmonary function
studies for many months.
Higher risk factors
There is a no doubt that various high risk factors are associated
with severity of the disease which was evidenced by the various studies
from all part of the worlds. These are prematurity37, children with
immunodeficiency (acquired or congenital)38, underlying respiratory
illnesses such as chronic lung disease (CLD; known as BPD)36 and those
with significant congenital heart disease39.
Male sex, young age, day care attendance, and crowding/siblings
are independent risk factors for the development of severe RSV LRI40.
Gestational age, birth order, birth weight, and exposure to tobacco
14
smoke affected the prevalence and severity of RSV-related lower
respiratory tract disease.
Iqbal et al25 he found that 38 percent of the children were breast
fed. This is different from Arif A27 (66%) and Rani R42 (91%). This
difference may be due to relatively small sample size in their studies (85
and 100 respectively). He also documented that 38% of the children had
family history of acute respiratory tract illness and 14% children had
family history of allergy. Christakis DA et al43 reported 57% children
with family history of acute respiratory tract illness and 71% family
history of allergy.
The severity of the four epidemic seasons, seven predictors for
hospitalization for RSV infection were found in the bivariate analysis:
number of children in the family, chronological age at the onset of RSV
season, birth weight, gestational age, birth order, daycare attendance and
previous RSV infections. In the logistic regression analysis, only three
predictors were detected: chronological age at the beginning of RSV
season, birth weight category and birth order41.
Vanda Bento et al44 ,a total of 328 children were studied  41% of
the patients were from a poor socioeconomic context, 55.8% had older
15
siblings and  32.2% had smoking parents and 11.3% had reactive airway
disease.
A hospital based prospective study from India was carried by Das
et al45 found that birth weight (LBW)/premature babies & non
breastfeeding practices were significant risk factors for severe
bronchiolitis.
Although there is no doubt that secondhand Environmental
Tobacco Smoke (ETS) exposure contributes to lower respiratory tract
infection in infants and young children in developing countries46 and
industrialized nations47 the evidence for a specific effect on RSV LRTI is
less clear.
Carroll et al48 present probably the largest population-based study
of term infants with bronchiolitis to determine the association between
maternal asthma, maternal smoking, and the incidence and severity of
bronchiolitis. Infants of mothers with asthma who smoked had a higher
risk for emergency department visits and hospitalizations. Although
maternal smoking increased the risk of prolonged hospitalization by 19%,
if the mother was smoking and had asthma the increased risk was 38%.
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The major limitation of his study is that other risk factors that are
well known to be associated with hospitalization for RSV or bronchiolitis
such as an index of crowding that includes the number of sibling and
adults in the household, day-care exposure, or day-care exposure of
siblings or the presence of siblings, birth during the first half of the RSV
season, and a putative risk factor (breastfeeding) were not included in
these analyses40.
In an examination of atopic risk factors, although a maternal
history of asthma was considered, that of other relatives or other
conditions such as atopic dermatitis or allergic rhinitis in first-degree
relatives was not included in the analysis49.
An initial study in Rochester, New York38, conducted between
1974 and 1976, suggested that there is a significant difference between
children hospitalized with RSV and controls in the amount of
environmental tobacco smoke exposure.
SHS exposure may increase the severity of bronchiolitis in RSV-
infected infants by enhancing production of cysteinyls LTE4 in infants50.
D G Sims et al51, in his study concluded that large families and
overcrowding among poorer families seem to lead to a higher incidence
17
of RSV infection, and measures to reduce overcrowding and improve
housing should help to reduce the spread of infection. Breast-feeding also
protects infants from infection.
Lower Socio-Economic groups, where the risk of RSV disease is
high. Iqbal et al25 study had documented that 62% of the children
belonging to poor socioeconomic class which is consistent with that
reported by Sarfraz et al52.
Laboratory investigations
Chest x ray
AAP1 said that radiography may be useful when the hospitalized
child does not improve at the expected rate, if the severity of disease
requires further evaluation, or if another diagnosis is suspected.
Chest X-rays, although nonspecific, can provide complementary
diagnosis. Visible radiographic manifestations include diffused lung
hyperinflation with increased lung volume, hyperlucency, flattening of
the diaphragms, and prominent bronchovascular markings with an
interstitial infiltrate pattern. Atelectatic areas from mucoid plugging and
low-density infiltrates are often seen, and pleural thickening may also be
evident.
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Two studies36, 37 suggested that the presence of consolidation and
atelectasis on a chest radiograph is associated with increased risk for
severe disease. One study showed no correlation between chest
radiograph findings and baseline severity of disease.
In prospective studies including one randomized trial, children with
suspected LRTI who received radiographs were more likely to receive
antibiotics without any difference in time to recovery53. Current evidence
does not support routine radiography in children with bronchiolitis.
However, Chest X rays may be obtained as clinically indicated when the
diagnosis of bronchiolitis is not clear and when subtle worsening of the
respiratory status occurs, or with preexisting cardiac or lung disease53.
Other diagnostic tests
Bronchiolitis is a clinical diagnosis that does not require diagnostic
testing. The clinical utility of diagnostic testing in infants with suspected
bronchiolitis is not well supported by evidence54. The occurrence of
serious bacterial infections (SBIs; e.g. urinary tract infections [UTIs],
sepsis, meningitis) is very low55. The use of complete blood counts has
not been shown to be useful in either diagnosing bronchiolitis or guiding
its therapy.
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Virology tests for RSV, the knowledge gained from such testing
rarely alters management decisions or outcomes for the vast majority of
children with clinically diagnosed bronchiolitis.
Management
General
The main benefits of hospitalization of infants with acute
bronchiolitis are:
The careful monitoring of clinical status
Maintenance of a patent airway (through suctioning & mucus
clearance).
Maintenance of adequate hydration
Parental education
Monitoring of clinical status
 In bronchiolitis, monitoring has a significant part of the treatment
because of the dynamic nature of the disease. Children may become
worsen after admission that is why we have to assess effect of  respiratory
distress on the feeding ability, the hydration status of the children,
respiratory rate, increasing respiratory effort and cyanosis (oxygenation
by pulse oximetry).
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AAP1 stated that the substantial temporal variability in physical
findings as well as potential differences in response to therapy may need
repeated observation over a period of time rather than a single
examination may provide a more valid overall assessment.
Pulse oximetry has been rapidly adopted into clinical
assessment of children with bronchiolitis on the basis of data suggesting
that it can reliably detect hypoxemia that is not suspected on physical
examination36.
Few studies have assessed the effectiveness of pulse oximetry to
predict clinical outcomes. Among inpatients, perceived need for
supplemental oxygen that is based on pulse oximetry has been associated
with higher risk of prolonged hospitalization, ICU admission, and
mechanical ventilation56. Among outpatients, available evidence differs
on whether mild reductions in pulse oximetry (less than 95% on room air)
predict progression of disease or need for a return visit for care57.
Oxygen
AAP1 recommendation is supplemental oxygen is indicated if oxy-
hemoglobin saturation (SpO2) falls persistently below 90% in previously
healthy infants. If the SpO2 does persistently fall below 90%, adequate
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supplemental oxygen should be used to maintain SpO2 at or above 90%.
Oxygen may be discontinued if SpO2 is at or above 90% and the infant is
feeding well and has minimal respiratory Distress.
The infant with acute bronchiolitis and respiratory distress should
be hospitalized if sustained SpO2 is below 92% in room air58. Sometimes
respiratory failure can requires mechanical ventilation especially in high
risk groups.
Hydration status
The mainstays of therapy for patients with bronchiolitis are fluid
replacement and oxygen supplementation. These infants are mildly
dehydrated because of decreased fluid intake and increased fluid losses
from fever and tachypnea. The goal of fluid therapy is to replace deficits
and provide maintenance requirements.
Excessive fluid requirements should be avoided as this may
promote interstitial edema formation which was evidenced by the
possibility of fluid retention related to production of ADH has been
reported in patients with bronchiolitis59. Clinicians should adjust fluid
management accordingly.
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Airway clearance
Suctioning of the nares may provide temporary relief of nasal
congestion. There is no evidence to support routine “deep” suctioning of
the lower pharynx or larynx.
A Cochrane review 123 found 3 RCTs that evaluated chest
physiotherapy in hospitalized patients with bronchiolitis. No clinical
benefit was found using vibration and percussion techniques.
Bronchodilators
Bronchodilators have been commonly used in the management of
bronchiolitis. A Canadian study36 found that 78% of those hospitalized
with bronchiolitis received bronchodilators. A survey of pediatric
allergists and pulmonologists in the United States61 found that 86%
recommended a trial of bronchodilators for this condition. Similarly, in a
survey of pediatric infectious disease specialists in Europe, the majority
used bronchodilators for treatment of bronchiolitis62.
Prior meta-analyses64 and a systematic review 65 have shown that
bronchodilators may improve clinical symptom scores but they do not
affect disease resolution, need for hospitalization or length of stay.
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Glucocorticosteroids
Despite the prominent role that inflammation plays in the
pathogenesis of airway obstruction, corticosteroid use remains
controversial.
In a recent randomized, double-blind, placebo controlled trial in
children admitted to the hospital with RSV bronchiolitis, prednisolone
(1mg/kg/day orally for 7 days) was thought to be effective in accelerating
the clinical recovery of these children62.
One study 65 concluded that oral dexamethasone therapy does not
affect the clinical course of children hospitalized with bronchiolitis.
Currently, the evidence for the use of glucocorticosteroids for children
with bronchiolitis is equivocal1.
Antibiotics
AAP1 recommended that antibacterial medications should be used
only in children with bronchiolitis who have specific indications of the
coexistence of a bacterial infection. Otherwise antibiotics are not
recommended for bronchiolitis.
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Ribavirin
The current recommendation of the AAP1 is that ribavirin aerosol
therapy may be considered only patients with complicated CHD,
including pulmonary hypertension; patients with BPD, cystic fibrosis, and
other chronic lung disease; patients with underlying immunosuppressive
disease; patients who are severely ill with or without mechanical
ventilation; and hospitalized patients who are younger than 6 weeks or
who have underlying conditions such as multiple congenital anomalies or
certain neurological and metabolic diseases.
Parental education
According to the AAP1, frequent hand washing is the most
important strategy for reducing the burden of RSV disease. Hands should
be decontaminated before and after direct contact with patients, after
contact with inanimate objects in the direct vicinity of the patient, and
after removing gloves. Alcohol-based rubs are preferred for hand
decontamination. An alternative is hand-washing with antimicrobial soap.
Clinicians should educate personnel and family members on Hand
sanitation.
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Infants should not be exposed to passive smoking. Breastfeeding is
recommended to decrease a child’s risk of having lower respiratory tract
disease. General prevention measures that can be undertaken by family
members include smoking cessation, breastfeeding, and avoiding
situations, whenever possible, where exposure to RSV cannot be
controlled.
McCartney KK66 et al clearly demonstrated that promoting hand-
washing and good hygiene practices to be adopted when coughing can
help reduce the transmission of acute respiratory infection.
Palivizumab
Passive immunoprophylaxis with palivizumab, the only agent
approved by the FDA, for the prevention of RSV and reduces
hospitalization in high-risk children. Immunoprophylaxis is indicated
only for certain high-risk children. The AAP1 has issued specific
guidelines for RSV immunoprophylaxis with palivizumab. Other
therapies are emerging for the prevention of RSV, including a new,
enhanced-potency, humanized RSV monoclonal antibody and several
different types of vaccines.
AIM OF THE STUDY
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AIM OF THE STUDY
• To study the clinical profile and outcome (hospital stay) of
bronchiolitis in age group of 1 – 24 months.
• To analyze the identifiable risk factors for severity of bronchiolitis.
MATERIALS
&
METHODS
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MATERIALS AND METHODS
Study design              :   Prospective descriptive study.
Study Period              :  Aug 2009 to Aug 2010.
Sample size                 :   222 patients.
Study place                 :   Institute of Social Pediatrics, Government
                   Stanley Hospital, Chennai.
Inclusion criteria:-
1. Previously normal children aged 1 – 24 months.
2. First episode of wheeze suggestive of bronchiolitis as per AAP
guidelines.
Exclusion criteria:-
1. Children aged <1 month and > 24 months.
2. Previous episode of wheezing.
3. Children with underlying respiratory disease (CLD, Recurrent
pneumonia), cardiac disease (congenital heart disease and myocarditis),
preterm, immunodeficiency (congenital or acquired) and signs of sepsis.
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Methodology:-
Children of age group 1 to 24 months who were previously normal,
presented with symptoms of viral upper respiratory prodrome
followed by increased respiratory effort and wheezing for the first
time without any underlying respiratory (CLD known as BPD and
Recurrent pneumonia), Cardiac (Congenital Heart Disease and
Myocarditis) and Immunodeficiency (Congenital or acquired) were
taken to this study as per AAP Guidelines.
From the history, risk factors were analyzed, which have impact on
severity of the disease.
The factors are :
Birth Weight, Exclusive Breast Feeding, Bottle Feeding,
Parental Asthma, Type of family, No. of Children, Socio-Economic
Status (Modified Kuppusamy Scales), Passive smoking and Indoor
allergen.
To identify the vulnerable age group who exposed to URI in the
family members were noted.
Temperature was recorded, Children with temperature >39°C were
subjected to septic workup.
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Septic workup includes complete blood count, C Reactive Protein,
Blood culture and CXR to rule out serious bacterial infections.
Those who showed positive blood culture, CRP +ve (>6ng) and
patchy infiltration in CXR were excluded from the study.
Severity was assessed by Wood Downes Score
Score Wheezing Retraction RR HR Ventilation cyanosis
0 No No <30 <120 Good
Symmetrical
Yes
1 End
expiratory
Subcostal/
intercostal
31-45 >120 Regular
Symmetrical
No
2 All
expiratory
Supraclavicular
+ nasal flaring
45-60 - Very
reduced
-
3
Both
inspiration
and
expiration
+intercostal +
suprasternal >60 -
Silent
thorax -
Children who scored below 3 classed as mild cases, 4-7 classed as
moderate and 8-14 classed as severe cases.
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Hypoxemia was assessed by pulse oximetry.
Children with oxygen saturation below 92% on room air were
admitted and treated under PICU care, rest were treated in the
ward.
All children were who had SpO2 below 90% on room air, were
treated with humidified warm oxygen as per AAP and intravenous
fluids as per their needs.
Duration of oxygen requirement and duration of hospital stay were
analyzed.
Statistical methods used:-
The information collected regarding all the selected cases were
recorded in a Master Chart. Data analysis was done with the help of
computer using Epidemiological Information Package (Epi Info 3.4.3).
Using this software range, frequencies, percentages, means,
standard deviations, chi square and P values were calculated. Pearson chi
square test was used to test the significance of difference between two
variables. A ‘p’ value less than 0.05 taken to denote significant
relationship. If value of ‘p’ is more than 0.05 then is taken to denote
absence of relationship between the two variables.
RESULTS
&
ANALYSIS
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RESULTS AND ANALYSIS
A total of 222 cases were analyzed in our study. Mean age was 6.4
months with Standard deviation of 4.6 months.
Table-I Age distribution of Bronchiolitis
Age
(In months)
Children
No. %
1 – 6 130 58.6
7 -12 66 29.7
13 – 18 20 9.0
19 - 24 6 2.7
Total 222 100
Age distribution was more among young children (1-12months).
196 cases (88.3%) were belonged to 1 – 12 months of age, rest of 26
cases (11.7%) were belonged to 13 – 24 months of age groups.
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Table – II Sex distribution of Bronchiolitis
Sex
Children
No. %
Male 129 58.1
Female 93 41.9
Total 222 100
Bronchiolitis was more commonly presented by males (129) than
females (93).
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Table - III Age wise sex distribution of bronchiolitis
Age
(In months)
Male Female
No. % No. %
1 - 6 75 58.1 55 59.2
7 -12 38 29.5 28 30.1
13 -18 13 10.1 7 7.5
19 -24 3 2.3 3 3.2
‘P’
0.001
Significant
1 – 12 months age distribution were more in male than female, In
rest, sex was equally distributed. This difference is statistically
significant.
1-6mo
7-12mo
13-18mo
19-24mo
75
38
13
3
55
28
7
3
Age wise sex distribution of bronchiolitis
Male Female
34
Table – IV Seasonal Pattern of bronchiolitis
Month - Year No %
Aug-09 11 4.9
Sep-09 7 3.1
Oct-09 10 4.5
Nov-09 32 14.4
Dec-09 49 22.1
Jan-10 20 9.1
Feb-10 12 5.5
Mar-10 8 3.7
Apr-10 7 3.1
May-10 5 2.2
Jun-10 7 3.1
Jul-10 18 8.1
Aug-10 36 16.2
Total 222 100
 Bronchiolitis admissions were more commonly occurred in
December (49) and November (32) followed by January (20) and
February (12).
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Table - V Severity of bronchiolitis
Severity
Children
No. %
Mild 90 40.6
Moderate 88 39.6
Severe 44 19.8
Total 222 100
40.6% (90) of children were mild cases.
39.6% (88) of children were moderate cases.
19.8% (44) of children were severe cases
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Table – VI Severity of bronchiolitis among different age groups
Age
(In months)
Mild Moderate Severe
No. % No. % No. %
1 – 6 41 45.6 57 64.8 32 72.7
7 – 12 33 36.7 22 25.0 11 25.0
13 -18 13 14.4 6 6.8 1 2.3
19 -24 3 3.3 3 3.4 o 0.0
‘P’
0.03
Significant
Severity was more among 1-6 mo age groups, afterwards severity
decreases with increasing age. There exists statistically significant
relationship between age and severity.
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Table VII Sex Vs Severity of bronchiolitis
Sex
Mild Moderate Severe
No. % No. % No. %
Male 58 64.4 47 53.4 24 54.5
Female 32 35.6 41 46.6 20 45.5
‘P’
0.29
Not Significant
Sex of the children does not have statistical significant with severity
of the bronchiolitis.
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Table VIII Symptoms of bronchiolitis in different age groups
A) Irritable cry among different age groups
Irritable cry was most commonly presented by 1-6 months of age (75.4
%) followed by 7-12 months of age (23.0%). This is doing statistically
significant.
Age
(in months)
Irritable cry
Yes No
No. % No. %
1-6 92 75.4 38 38.0
7-12 28 23.0 38 38.0
13-18 2 1.6 18 18.0
19-24 0 0.0 6 6.0
‘P’
0.0001
Significant
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B) Poor feeding among different age groups
72.7% (96) of children belonging to 1-6 months of age group were
commonly presented with poor feeding followed by 22.8% of children
belonging to 7-12 months of age group. This is doing statistically
significant.
Age
(in months)
Poor feeding
Yes No
No. % No. %
1-6 96 72.7 34 37.8
7-12 30 22.8 36 40.0
13-18 4 3.0 16 17.8
19-24 2 1.5 4 4.4
‘P’
0.0001
Significant
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C) Aspiration while feeding among different age groups
Aspiration while feeding (98.4%) was more commonly presented by
age group of 1-12months than rest. This relationship is doing statistically
significant.
Age
 (in months)
Aspiration while feeding
Yes No
No. % No. %
1-6 48 75.0 82 51.9
7-12 15 23.4 51 32.3
13-18 1 1.6 19 12.0
19-24 0 0.0 6 3.8
‘P’
0.0001
Significant
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Table -IX Symptoms presentation Vs Severity of bronchiolitis
A) Irritable cry vs. severity of bronchiolitis
Irritable
cry
Mild Moderate Severe
No. % No. % No. %
Yes 32 35.6 55 62.5 35 79.5
No 58 64.4 33 37.5 9 20.5
‘P’
0.001
Significant
B) Poor feeding vs. Severity of bronchiolitis
Poor
feeding
Mild Moderate Severe
No. % No. % No. %
Yes 40 44.4 55 62.5 36 81.8
No 50 55.6 33 37.5 8 18.2
‘P’
0.001
Significant
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C) Aspiration while feeding vs. severity of bronchiolitis
These symptoms (irritable cry, poor feeding and aspiration
while feeding) were significantly predicting the severity of the
bronchiolitis.
Aspiration
while
feeding
Mild Moderate Severe
No. % No. % No. %
Yes 6 6.7 21 23.9 37 84.1
No 84 93.3 67 76.1 7 15.9
‘P’
0.004
Significant
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Table X Birth Weight Vs Severity of bronchiolitis
 Children with LBW had more severe presentation of the
bronchiolitis than children with birth weight >2.5kg.
Severity
Birth Weight(in Kg)
<2.5 >2.5
No. % No. %
Mild 21 24.4 69 50.7
Moderate 41 47.7 47 34.6
Severe 24 27.9 20 14.7
‘P’
0.0003
Significant
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Table XI Exclusive Breast Feeding Vs Severity of bronchiolitis
Children who were exclusively breast fed presented with lesser
severity. Very high significant exist between the two variables.
EBF
Mild Moderate Severe
No. % No. % No. %
Yes 43 47.8 43 48.9 7 15.9
No 47 52.2 45 51.1 37 84.1
‘P’
0.001
Significant
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Table XII Bottle Feeding Vs Severity of bronchiolitis
 Bottle feeding increases the severity of the disease. This
relationship is statistically significant.
Bottle
Feeding
Mild Moderate Severe
No. % No. % No. %
Yes 56 62.2 47 55.4 35 79.5
No 34 37.8 41 46.6 9 20.5
‘P’
0.01
Significant
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Table XIII Parental Asthma Vs Severity of bronchiolitis
There is no significant relationship between these two variables.
Table XIV Passive Smoking Vs Severity
      Severity of the bronchiolitis was more among the children exposed to
passive smoking than not exposed. This relationship is statistically
significant.
Parental
Asthma
Mild Moderate Severe
No. % No. % No. %
Yes 19 21.1 22 25.0 12 27.3
No 71 78.9 66 75.0 32 72.7
‘P’
0.69
Not Significant
Parental
Asthma
Mild Moderate Severe
No. % No. % No. %
Yes 33 36.7 42 47.7 27 61.4
No 57 63.3 46 52.3 17 38.6
‘P’
0.02
Significant
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Table XV Indoor Allergens Vs Severity of bronchiolitis
When the children exposed to the indoor allergens presented with severe
bronchiolitis. There is a significant relationship between indoor allergens
and severity of the bronchiolitis.
Severity
Indoor Allergens
Yes No
No. % No. %
Mild 20 26.3 70 47.9
Moderate 38 50.0 50 34.3
Severe 18 23.7 26 17.8
‘P’
0.001
Significant
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Table XVI Age at risk for bronchiolitis when exposure to URI in
family members
1-6months age groups (63.3%) were prone to have a disease than
the rest of the age groups. There is a significant difference between two
variables.
Age
(in months)
URI in family members
Yes No
No. % No. %
1-6 86 63.3 44 51.1
7-12 41 30.1 29 29.1
13-18 7 5.1 13 15.1
19-24 2 1.5 4 4.7
‘P’
0.02
Significant
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Table XVII Type of family VS Severity of bronchiolitis
Children residing in joint family were presented with more
severe disease than nuclear family. This relationship is statistically
significant.
Type of
family
Mild Moderate Severe
No. % No. % No. %
Joint 33 36.7 46 52.3 27 61.4
Nuclear 57 63.3 42 47.7 17 38.6
‘P’
0.02
Significant
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Table XVIII No. of children Vs Severity of bronchiolitis
 As the birth order increases presentation of the disease was severe.
This relationship is statistically significant.
No. of
Children
Mild Moderate Severe
No. % No. % No. %
1 38 42.2. 31 23.6 12 27.3
2 29 32.2 32 36.4 10 22.7
>2 23 25.6 35 36.8 22 50.0
‘P’
0.02
Significant
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Table XIX SES Vs Severity of bronchiolitis
      Majority of the severe presentation of bronchiolitis was belonged
to Class IV Socio Economic Status (72.8%) followed by Class III & V
(13.6).
SES
Mild Moderate Severe
No. % No. % No. %
Class I - - - - - -
Class II 3 100 - - - -
Class III 37 52.1 28 39.4 6 8.5
Class IV 45 34.9 52 40.3 32 24.8
Class V 5 26.3 8 42.1 6 31.6
‘P’
0.01
Significant
SES Vs Severity of bronchiolitis
0 0 0
3
0 0
37
28
6
45
52
32
5
8
6
Class I Class II Class III Class IV Class V
SES Vs Severity of bronchiolitis
Mild Moderate Severe
52
Table XX Oxygen requirement VS Severity of bronchiolitis
In our study we found that average duration of O2 supplementation
was 2.36days. Severe cases were needed prolonged oxygen requirement.
There exists statistically significant relationship between severity and
oxygen requirement.
Oxygen
requirement
Mild Moderate Severe
No. % No. % No. %
<72HRS 83 98.9 31 35.2 0 0.0
>72HRS 7 1.1 57 64.8 44 100.0
‘P’
0.001
Significant
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Table XXI Duration of Hospital stay Vs severity of bronchiolitis
In our study, median duration of hospital stay was 4 days. Severe
cases of bronchiolitis needed prolonged stay in hospital than mild and
moderate cases which is statistically significant.
Duration
of
Hospital
stay
Mild Moderate Severe
No. % No. % No. %
<7days 87 96.7% 85 96.6% 33 75.0%
>7days 3 3.3% 3 3.4% 11 25.0%
‘P’
0.001
Significant
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DISCUSSION
Joseph L Mathew et al67, he mentioned that bronchiolitis is
regarded as the most common LRTI among infants in developed
countries. In our country too, it is a significant problem judging by the
frequency of wheezing episode among young infants.
Age distribution of bronchiolitis
In our study, 58.6% were 1 -6mon age groups, 29.7% were 7–
12mon age groups, nearly 88.3% (196) were belonged to 1 – 12mon age
groups which was similar to studies done by Caroline Breese Hall et al8
and Uyan et al26, in their studies 85% of children belonged to less than
12months.
One study from U. K.68 63.6% was less than 6 months, 92.8% were
less than 12 months, and this study was on populations under 2 years of
age.
In our study, 11.7% of children were 12 – 24 months of age
which was similar to study from Greece69, found that only 10 % of study
population were above 12 months of age. P. Flores et al63, 10.6% were
belonged to 12 – 24 months of age.
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In our study, mean age was 6.4 months. In Uyan et al26, mean age
was 6.9 months which was similar to our study. Other studies by Arif A
et al27 and Iqbal et al25 reported the mean age was 5.43 months and 11.5
months respectively. A.G. Constantopoulos et al69, mean age was 5. 98
months. R.Y.T. Sungi et al6 was reported the mean age was 5 months.
These findings are explained that bronchiolitis was most
commonly presented by 5 to 7 months of age groups.
Sex distribution of bronchiolitis
In our study we observed that male (58.1%) predominance which is
in agreement with reports from other parts of the world26, 6. They
observed male predominance of 58% in their study.
Male predominance was significantly noted below 12
months of age groups in our study; in rest sex was equally distributed.
Seasonal Pattern of bronchiolitis
In our study, most cases were admitted between November and
March which means outbreak of bronchiolitis most likely occurs in winter
and early spring which was similar to studies done in west.
AAP1 stated that in their guideline, the highest incidence of RSV
occurring between December and March.  Hans-Olav Fjaerli et al7 done
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a population based retrospective study in Northern Europe; he reported
that the high number of admission was recorded during winter months
December – April.
John et al9 done a study in South India, he stated that acute
bronchiolitis tented to occur in outbreaks between August and November.
In Hong Kong, R.Y.T.Sungi et al6 in his study, he surprised to find
that acute bronchiolitis was prevalent in the middle part of the year,
between April and October. One study from U.K.68 clearly stated that the
majority of admission (93.8%) occurred between months of November
and March each year.
Symptoms presentation of bronchiolitis
Our study populations were hospitalized children who invariably
(100%) presented with respiratory distress. Irritable cry (98.4%), poor
feeding (95.5%) and aspiration while feeding (98.4%) were more
commonly presented by age group of 1-12months. These symptoms were
significant with severe clinical presentation of disease (P= 0.0001).
Iqbal et al25, he studied among age group between 2months to
2years, he found that 91% had respiratory distress at the time of
presentation and 32% had decreased feeding.  Study conducted by Arif A
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et al36 concluded that respiratory distress (97.5%) was consistent clinical
feature. The results of our study are also consistent with previous studies
where authors found that respiratory distress was the main presenting
feature of acute bronchiolitis.
Study from U.K.31, concluded that the frequency of swallowing
was slightly higher, the volume of milk consumed per swallow was
almost half the amount consumed by the comparison group. Coordination
of breathing with swallowing was also less effective which explains the
symptom presentation of poor feeding in younger age groups.
Severe disease: signs and symptoms associated with poor feeding
and respiratory distress characterized by tachypnea, nasal flaring, and
hypoxemia said by the AAP1.  Aspiration is likely to play a role when
rapid deterioration occurs in infants with RSV bronchiolitis33.
There is a conflicting finding by A. Maffey et al32, his study was
the risk of aspiration in bronchiolitis in hospitalized infants. He studied
on only 15 infants; he found that there was a no risk of aspiration during
acute bronchiolitis.
58
Analysis of Severity among identified risk factors
In our study population, 40.6 %( 90) were mild cases, 39.6 %( 88)
were moderate cases and 19.8 % (44) were severe cases which was
assessed by woods downes scores.
Severity among different age groups
Young age remains the most important predictor for severe
bronchiolitis said by AAP1. This was shown by our study that 97.7% of
children among 1 – 12mon age group were presented with severe
presentation. Caroline Breese Hall et al8 evaluated risk factor for severe
disease; he concluded that only young age imposed a significantly greater
risk for severe illness among children with RSV infection. Young age
especially less than 3 months was a risk for severe disease37.
Sex vs. severity of bronchiolitis
In our study we found that sex was not statistically significant with
severity of disease. Whereas Eric A.F Simoes et al40 concluded in his
study that male sex was independent risk factor for the severe
bronchiolitis.
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Birth weight vs. Severity of bronchiolitis
We studied on Term babies with low birth weight; we
demonstrated that the low birth weight was predicting risk and the
severity of the disease which was proved by the study done by Carroll
et al48, in his population based retrospective study on 103 670 term, he
found that analysis of the linear trend for birth weight in 500-g increments
demonstrated a significant negative association with bronchiolitis risk for
hospitalization which was indirectly reflecting the severity of the disease.
Study from U.S.70concluded although infants weighing <2500g at
birth are at increased risk for dying with bronchiolitis, the majority of
bronchiolitis deaths occur among infants of normal birth weight.
Type of feeding practice vs. Severity of bronchiolitis
Our study found that non breast feeding practice was predicting the
risk for severity of the disease. The same finding was demonstrated by
various studies from all over the world.
Study from India by Das PK et al45, he was clearly mentioned that
non breast feeding practice as significant risk factor for severe
bronchiolitis.
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M A P S Downham et al71 concluded in his study that the incidence
of breast-feeding among infants admitted to hospital with RSV infection
was significantly lower. Therefore breast-feeding seems to offer
protection against illness severe enough to require hospital admission
even though the occasional occurrence of frank bronchiolitis in fully
breast-fed infants makes it clear that this protection is not complete. C R
Pullan et al72 concluded that the breast feeding may be an independent
factor influencing the severity of the bronchiolitis.
The conflicting finding with above studies was documented by Eric
A.F Simoes et al40 stated  that there was a lack of evidence for non breast
feeding practice appear to increase the risk of severe RSV infection. His
finding was justified by the study done by Toms et al72, he has shown that
breast milk varies in its anti-respiratory syncytial virus activity which
explains that breast-feeding does not give complete protection.
Regardless of the reasons for protection, the strong association
between breastfeeding and lack of severe RSV infection suggests that
increasing the proportion of mothers who breastfeed their infants could
result in substantial disease reduction.
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Parental asthma vs. severity of bronchiolitis
In our study parental asthma did not predict the severity of disease
significantly. Our result was supported by Carbonell Estrany x et al73.
But one study40 demonstrated an association between maternal asthma
and less severe hospitalized disease.
Passive smoking vs. severity of bronchiolitis
In the study from China46 secondhand environmental tobacco
smoke exposure early age of life increases the risk for severe respiratory
illness like bronchiolitis. The same result was demonstrated in our study.
Bryn H Salt et al50 concluded that SHS exposure may increase the
severity of bronchiolitis in RSV-infected infants.
In a more recent nested case control study from the Danish birth
cohort49 clearly stated that tobacco smoke exposure was shown to be
unequivocally associated with an increased risk for severe RSV
bronchiolitis leading to hospitalization.
Indoor allergen vs. severity of bronchiolitis
In our study we found out that those who were exposure to indoor
allergen were having severe clinical presentation of bronchiolitis.
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One study on developing countries concluded that indoor air
pollution in households using biomass fuels, the risk seems to be fairly
strong, presumably because of the high daily concentrations of pollutants
found in such settings and the large amount of time young children spend
with their mothers doing household cooking18.
Karen Morris et al74 in his study he analyzed that wood-burning
stove use and respiratory illness exposure were independently associated
with higher risk for severe disease. Cooking with wood-burning stoves
was associated with higher indoor air concentrations of respirable
particles which contributed for the severity of the disease which explains
our study result75.
Type of family vs. severity of bronchiolitis
The children from joint family were presented with severe form of
the disease than nuclear family which indirectly explained the
overcrowding which was supported by previous studies40, 51.
No of children in the family vs. severity of bronchiolitis
Our study result was consistent with Holman RC et al70, he stated
that in his study that increasing birth order was a risk factor for severity
of bronchiolitis.
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One study from Italy76, concluded that the only condition related to
demographic and social characteristic of the family was the number of
children in the family (being at least the second baby was a risk factor)
which was a risk factor for severe illness. The severity of disease was
associated with increasing number of sibling in the family48.
SES vs. Severity of bronchiolitis
In our study, we found that  lower socio-economic status were
presented with severe disease than higher socio-economic status which
explain that low SES peoples living with over crowing, poor ventilation
and high birth order.
Lower socio-economic status children were frequently presented
by severe illness8. Otherwise healthy, term infants who require
hospitalization were lower income population48.
Duration of oxygen requirement & Hospital stay
Christrophe Merguet et al, he studied on under one year age needed
the oxygen supplementation was one day. One study from Italy by Paolo
Di  Carlo  et  al110 documented the duration of oxygen requirement was
4.9days. In our study we found that average duration of O2
supplementation was 2.36days.
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Hans-Olav Fjaerli et al7 found that median length of stay was 4
days which was similar to our study. Caroline Breese Hall et al8 in his
study, median hospitalization was 2 days, the same finding was
documented by S A Despande et al94.
We also documented that duration of O2 requirement and duration
of hospital stay were statistically associated with severity of the disease
i.e. prolonged need for O2 and prolonged duration of hospital stay were
presented with very severe illness.
Conclusion
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CONCLUSION
In our study, we concluded that bronchiolitis occurred more
commonly in 1-12months of age group with male predominance
and most cases occurred in the winter and early spring.
Mild and moderate severity was the common presentation in our
study. 1-6months age group presented with severe form of
bronchiolitis.
Irritable cry, poor feeding and aspiration while feeding were more
common presentation for the age group of 1-12months and these
symptoms were significantly predicting the severity.
Children with LBW, not exclusively breast feed, bottle feed,
exposed to passive smoking and indoor allergens (wood burning
stoves and mosquito repellents), children residing in joint family,
increasing birth order and low Socio Economic Status were
significantly associated with severity of the bronchiolitis.
Sex and parental asthma were not significantly predicting the
severity of the bronchiolitis.
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Family members with URI were spreading the infection to the
younger age group (1-6months).
 Average duration of O2 supplementation was 2.36days. Median
duration of hospital stay was 4 days.
 Severe cases needed prolonged oxygen supplementation and
prolonged hospital stay which is significant.
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LIMITATIONS AND RECOMMENDATIONS
LIMITATIONS
Severity of bronchiolitis in this study was assessed by descriptive
study, hence relative risk could not be assessed.
 We studied on inpatients excluding preterm, CHD, underlying
respiratory illness and immunodeficiency. We could not estimate
the incidence of hospitalization.
RECOMMENDATIONS
Wash hands frequently to prevent spreading of the infection.
Keep children away from secondhand smoke.
Keep children (especially younger than 6months) away from other
people with acute respiratory tract infections.
Encourage the mother to give exclusive breast fed.
Avoid bottle feeding to prevent hospitalization for bronchiolitis.
Avoid using the wood burning stoves and mosquitoe coils.
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ANNEXURES
PROFORMA
• NAME OF THE CHILD :          AGE : SEX    :M/F
• ADDRESS                                     :
• COUGH                                           :                      YES  /  NO
• PROFUSE  CORYZA                     :                      YES  /  NO
• SNEEZING :                 YES  /  NO
• FEVER                 :                      YES  /  NO
• SHORTNESS OF BREATH           :                     YES  /  NO
• IRRITABLE  CRY       :                    YES  /  NO
• POOR  FEEDING                            :                      YES  /  NO
• ASPIRATION WHILE FEEDING  :                      YES /  NO
• BAD  CRP                                       :                    YES  /  NO
• SKIN  LESIONS                            :                    YES  /  NO
• GESTATIONAL  AGE                    :              TERM/PRETERM
• BIRTH WEIGHT                             :                   < 2.5 / >2.5 kg
• NICU ADMISSION                         :                     YES  /  NO
• PLACE  OF DELIVERY                 : DOMICILIARY /
                                                                             INSTITUTIONAL
• EXCLUSIVE BREAST FEEDING :                     YES  /  NO
• BOTTLE FEEDING :                   YES  /  NO
• PARENTAL  ASTHMA                  :                     YES  /  NO
• FAMILY  TYPE                              :            JOINT / NUCLEAR
• NO  OF CHILDREN : ONE/ TWO/MORE THAN TWO
• SOCIO ECONOMIC  STATUS :    CLASS I / II / III / IV / V
     (MODIFIED KUPPUSAMY SCALE)
•  PASSIVE  SMOKING          : YES  /  NO
• INDOOR  ALLERGENS         :       YES  /  NO
• CONTACT WITH OPEN CASE OF ADULT  TB :    YES / NO
• URI IN FAMILY MEMBERS :       YES / NO
• FEVER          :        <390C                   >390C
• SEVERITY ASSESSING  SCORE :
Score Wheezing Retraction RR HR Ventilation Cyanosis
0 No No <30 <120
Good
Symmetrical Yes
1
End
expiratory
Subcostal/
Intercostal 31-45 >120
Regular
Symmetrical No
2
All
expiratory
Supraclavicular
+ nasal flaring 45-60 -
Very
reduced -
3
Both
inspiration
and
expiration
+intercostal +
suprasternal >60 -
Silent
thorax -
Mild: below 3  Moderate: 4-7 Severe: 8-14
• SPO2 IN ROOM AIR :               <92%             >92%
• OXYGEN  SUPPLEMENTATION  &IV FLUIDS  NEEDED   :
                                                 <72HRS          >72HRS
• LABORATORY PARAMETERS :
WBC COUNT/DC/CXR/CRP/NEC
• OUTCOME (duration of hospital stay) : < 7days          > 7days
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KEY TO MASTER CHART
AGE                                         :    1. 1- 6months 2. 7-12months
              3. 13-18months 4. 19-24months
SEX                    :                    1.MALE 2.FEMALE
COUGH                                    :                          1.YES / 2.NO
PROFUSE  CORYZA              :                          1.YES  / 2. NO
SNEEZING :                        1.YES / 2. NO
FEVER :                   1. YES / 2. NO
SHORTNESS OF BREATH    :                 1.YES / 2. NO
IRRITABLE  CRY           :                 1.YES  / 2. NO
POOR  FEEDING                      :                         1. YES  / 2. NO
ASPIRATION WHILE FEEDING      :               1.YES / 2. NO
BIRTH WEIGHT                       :                       1.< 2.5 / 2.>2.5 kg
EXCLUSIVE BREAST FEEDING     :             1.YES / 2.NO
BOTTLE FEEDING                  :                  1.YES / 2. NO
PARENTAL  ASTHMA            :                          1.YES / 2. NO
TYPE  OF FAMILY :    1.JOINT/2.NUCLEAR
NO. OF CHILDREN   :     1.ONE/ 2.TWO/3.MORE THAN TWO
S E S      :   1.CLASS I /2. CLASS II /3.CLASS III / 4.CLASS IV /
                              5.CLASS V
PASSIVE SMOKING                 :                   1. YES / 2. NO
INDOOR ALLERGENS :                   1. YES / 2. NO
URI IN FAMILY MEMBERS         :                     1.YES /2. NO
SEVERITY ASSESSING SCORE   :
                1. MILD              2.MODERATE      3.SEVERE
SPO2 IN ROOM AIR             :              1. <92%           2.  >92%
OXYGEN  &IV FLUIDS  NEEDED   : 1. <72HRS    2.  >72HRS
OUTCOME (duration of hospital stay): 1. < 7days     2.  > 7days
ABBREVATIONS
ABBREVIATIONS
AAP -  American Academy of Pediatrics
RSV - Respiratory Syncytial Virus
LRTI - Lower Respiratory Tract Infection
HMPV - Human Metapneumovirus
NANC - non adrenergic non cholinergic system
CGRP          - Calcitonin gene-related peptide
ADCC         - Antibody dependent cell mediated cytotoxicity
CLD - Chronic Lung Disease
BPD -         Bronchopulmonary Dysplasia
ETS -         Environmental Tobacco Smoke
SHS - Second Hand Smoke
LTE4 -         Leukotriene E4
SBI -         Serious Bacterial Infection
UTI - Urinary Tract Infection
Spo2 -   Oxy-hemoglobin saturation
ADH -  Anti Diuretic Hormone
RCT -   Randomized Controlled Trial
CHD -  Congenital Heart Disease
FDA -  Food and Drug Administration
EBF -   Exclusive Breast Feeding
CRP -   C –reactive protein
CXR -  Chest X Ray
LBW -         Low Birth Weight
URI -         Upper Respiratory Tract Infection
SES -         Socio-Economic status
